Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Cited In for PubMed (Select 10404820)

1.

B-RafV600E inhibits sodium iodide symporter expression via regulation of DNA methyltransferase 1.

Choi YW, Kim HJ, Kim YH, Park SH, Chwae YJ, Lee J, Soh EY, Kim JH, Park TJ.

Exp Mol Med. 2014 Nov 7;46:e120. doi: 10.1038/emm.2014.68.

3.

DNA methylation state of the galectin-3 gene represents a potential new marker of thyroid malignancy.

Keller S, Angrisano T, Florio E, Pero R, Decaussin-Petrucci M, Troncone G, Capasso M, Lembo F, Fusco A, Chiariotti L.

Oncol Lett. 2013 Jul;6(1):86-90. Epub 2013 Apr 18.

4.

Phase I trial of a new schedule of romidepsin in patients with advanced cancers.

Amiri-Kordestani L, Luchenko V, Peer CJ, Ghafourian K, Reynolds J, Draper D, Frye R, Woo S, Venzon D, Wright J, Skarulis M, Figg WD, Fojo T, Bates SE, Piekarz RL.

Clin Cancer Res. 2013 Aug 15;19(16):4499-507. doi: 10.1158/1078-0432.CCR-13-0095. Epub 2013 Jun 11.

5.

Role of metallothioneins in benign and malignant thyroid lesions.

Pula B, Domoslawski P, Podhorska-Okolow M, Dziegiel P.

Thyroid Res. 2012 Dec 28;5(1):26. doi: 10.1186/1756-6614-5-26.

6.

5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro.

Dom G, Galdo VC, Tarabichi M, Tomás G, Hébrant A, Andry G, De Martelar V, Libert F, Leteurtre E, Dumont JE, Maenhaut C, van Staveren WC.

Thyroid. 2013 Mar;23(3):317-28. doi: 10.1089/thy.2012.0388.

7.

Thyroid cancer: pathogenesis and targeted therapy.

Liebner DA, Shah MH.

Ther Adv Endocrinol Metab. 2011 Oct;2(5):173-95. doi: 10.1177/2042018811419889.

8.

Epigenetics modifications and therapeutic prospects in human thyroid cancer.

Catalano MG, Fortunati N, Boccuzzi G.

Front Endocrinol (Lausanne). 2012 Mar 19;3:40. doi: 10.3389/fendo.2012.00040. eCollection 2012.

9.

Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches.

Harris PJ, Bible KC.

Expert Opin Investig Drugs. 2011 Oct;20(10):1357-75. doi: 10.1517/13543784.2011.614230. Review.

10.

The role of epigenetic alterations in papillary thyroid carcinogenesis.

Eze OP, Starker LF, Carling T.

J Thyroid Res. 2011;2011:895470. doi: 10.4061/2011/895470. Epub 2011 Jun 14.

11.

DNA methylation in thyroid tumorigenesis.

Stephen JK, Chitale D, Narra V, Chen KM, Sawhney R, Worsham MJ.

Cancers (Basel). 2011 Jun 1;3(2):1732-43. doi: 10.3390/cancers3021732.

12.

Antiproliferation and redifferentiation in thyroid cancer cell lines by polyphenol phytochemicals.

Kang HJ, Youn YK, Hong MK, Kim LS.

J Korean Med Sci. 2011 Jul;26(7):893-9. doi: 10.3346/jkms.2011.26.7.893. Epub 2011 Jun 20.

13.

Recent advances in molecular diagnosis of thyroid cancer.

Legakis I, Syrigos K.

J Thyroid Res. 2011;2011:384213. doi: 10.4061/2011/384213. Epub 2011 Mar 23.

14.

Epigenetics meets endocrinology.

Zhang X, Ho SM.

J Mol Endocrinol. 2011 Feb;46(1):R11-32.

15.

The biology of the sodium iodide symporter and its potential for targeted gene delivery.

Hingorani M, Spitzweg C, Vassaux G, Newbold K, Melcher A, Pandha H, Vile R, Harrington K.

Curr Cancer Drug Targets. 2010 Mar;10(2):242-67. Review.

16.

Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways.

Hou P, Bojdani E, Xing M.

J Clin Endocrinol Metab. 2010 Feb;95(2):820-8. doi: 10.1210/jc.2009-1888. Epub 2009 Dec 11.

17.

Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.

Pilli T, Prasad KV, Jayarama S, Pacini F, Prabhakar BS.

Thyroid. 2009 Dec;19(12):1333-42. doi: 10.1089/thy.2009.0195. Review.

18.

Follicular thyroid cancer cell growth inhibition by proteosome inhibitor MG132.

Stoll SJ, Pitt SC, Chen H.

J Surg Res. 2009 Sep;156(1):39-44. doi: 10.1016/j.jss.2009.03.070. Epub 2009 May 3.

19.

Recent advances in molecular biology of thyroid cancer and their clinical implications.

Xing M.

Otolaryngol Clin North Am. 2008 Dec;41(6):1135-46, ix. doi: 10.1016/j.otc.2008.07.001. Review.

20.

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR.

J Clin Endocrinol Metab. 2008 Nov;93(11):4331-41. doi: 10.1210/jc.2008-1102. Epub 2008 Aug 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk